On the subject of clinical studies, one of the most established medical cannabis players, GW Pharma released results of a phase 2 in adult epilepsy this week...decidedly average results. Actually, proved no benefit over placebo...which is interesting in itself as placebo patients reduced seizures by 40%!! Who knew sugar and chalk was so effective??
https://seekingalpha.com/news/3332925-gw-pharmas-gwp42006-flunks-mid-stage-study-focal-seizures
Maybe we should get CSR to go into the medical field??
On the subject of clinical studies, one of the most established...
Add EPN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EPN (ASX) Chart |
Day chart unavailable